I still believe in science behind the IMU and all subject matter excerpts, however the primary issue with IMU is strategic differentiation from others. There are several Pharma companies in ASX (list below with few missing like ALA) trying to address cure for cancers and only few are at treatment and diagnostic stage, however IMU has strategical differentiation from others in respect that it is trying to address unmet need to all cancers rather than focusing in one particular cancer (this could be good or bad) and this strategy could fire back as this is capital and time intensive.
Considering all 4 platforms IMU's of drugs and trail stages of Ph1 and Ph2, TLX, RAC and IMM are far ahead comapared to IMU and the market is trusting these companies and recent capital raise and their SP support what market believes. LC may be really good subject matter expert and recent individual treatment case needs to supported by new data but she is loosing credibility as leader of the company (sometimes I feel she had a big mouth and can't understand what she wanted to communicate to the market rather than repeating same rant for several years and asking money in the market). The only way, she can prove that IMU science is working is with p-values and statistically significant data. I understand that she has borrowed a lot of money to buy IMU shares and haven't sold a single shares (that's confidence and trust) however this market needs data and needs sooner than later.
DYOR before buy and sell, I'm not at state where selling market any sense. As many investors, sinking share price is not a good feeling for anyone except shorters and they are the only one making money here and they do not care whether IMU will be successful or not. I understand anything below 5.8C would be buy but will wait to see where the SP is heading
ATX Amplia Therapeutics Treatment 1 BDX BCAL Diagnostics Diagnostics 2 CHM Chimeric Therapeutics Treatment 3 COV Cleo Diagnostics Diagnostics 4 CYC Cyclopharm Diagnostics 5 GTG Genetic Technologies Diagnostics 6 IIQ Inoviq Treatment & Diagnostics 7 IMM Imutep Treatment 8 IMU Imugene Treatment 9 IVX Invion Treatment 10 KAZ Kazia Therapeutics Treatment 11 NOX Noxopharm Treatment 12 OSL OncoSil Medical Treatment 13 PAB Patrys Treatment 14 PTX Prescient Therapeutics Treatment 15 PYC PYC Therapeutics Treatment 16 RAC Race Oncology Treatment 17 RAD Radiopharm Theranostics Treatment & Diagnostics 18 RHY Rhythm Biosciencs Diagnostics 19 TLX Telix Pharmaceuticals Treatment & Diagnostics 20 VHT Volpara Health Techbnologies Diagnostics
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
Why IMU is a multi multi bagger, page-24525
-
- There are more pages in this discussion • 907 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M |
Open | High | Low | Value | Volume |
5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35252 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 1753430 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 717241 | 0.058 |
8 | 1860543 | 0.057 |
3 | 1067860 | 0.056 |
20 | 2643992 | 0.055 |
6 | 1127777 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 1095176 | 20 |
0.061 | 520305 | 5 |
0.062 | 290000 | 4 |
0.063 | 100000 | 1 |
0.064 | 217000 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |